Novodiax Webinar Slides:

Rapid Immunodetection in Clinical & Pharmaceutical Applications

Rapid Immunodetection In Clinical and Pharmaceutical Applications Webinar

Jianfu Wang, PhD is President and CEO of Novodiax and an inventor of the polyHPR technology that is driving faster immunohistochemistry tests.  

Novodiax is working to provide meaningful improvements to patient care via these rapid technologies which are being applied today to such environments as; breast cancer testing, lymph node dissections, Mohs Micrographic Surgery or Covid testing to provide relevant information at the time of care.

Novodiax rapid immunoassay solutions Include:


Complete this form to view the webinar slides and submit any questions you may have

By submitting this form, you agree to receive marketing communications from Novodiax and to the terms of our Privacy Policy.